Endometrial Cancer, Risk Factors and Prevention Strategies: Perspectives of Patients and At-Risk Women

To learn more about women's attitudes toward and knowledge about endometrial cancer and options that might decrease the risk of developing

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Endometrial Cancer Endometrial Neoplasms Female Urogenital Diseases Female Urogenital Diseases and Pregnancy Complications Genital Diseases Genital Diseases, Female Genital Neoplasms, Female Neoplasms Neoplasms by Site Urogenital Diseases Urogenital Neoplasms Uterine Diseases Uterine Neoplasms

Age range

18 year and older

Sex eligibility

Female

Study type

Observational

Primary location

MD Anderson Cancer Center

Houston, Texas, 77030, United States

Location status: Recruiting

Location contact

Larissa Meyer Meyer, MD

CONTACT

[email protected]

713-745-0973

About this study

To obtain pilot data regarding women's attitudes and perspectives about endometrial cancer and potential endometrial cancer prevention strategies.

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Women who present to MD Anderson Cancer Center including MDA Houston Area Locations with a diagnosis of endometrial cancer
Women who present to MD Anderson Cancer Center including MDA Houston Area Locations with a diagnosis of abnormal uterine bleeding or endometrial hyperplasia
Women without a diagnosis of endometrial cancer or endometrial hyperplasia
Women must be at least 18 years or age
Women must be able to read, write, and speak English
Women must be willing and able to provide written informed consent

Exclusion criteria

Treatment and study plan

Qualitative interviews

Behavioral

Interviews will be conducted for approximately 45-60 minutes

Primary outcomes

Patient education

Time frame: Through study completion; an average of 1 year.

To build a patient tool for educating and empowering women to make informed decisions about endometrial cancer prevention strategies.

Study contacts

Contact information is provided by the study sponsor or research team.

Larissa Meyer, MD

CONTACT

[email protected]

(713) 745-0973

Sponsors and collaborators

Lead sponsor

M.D. Anderson Cancer Center

Other

Registry information

Important dates

Study start: 2024
Primary completion: 2026
Study completion: 2026
First posted: May 10, 2024
Registry last updated: Jul 16, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Recruiting